Abstract:Modulation of DNA base excision repair (BER) has the potential to enhance response to chemotherapy and improve outcomes in tumours such as melanoma and glioma. APE1, a critical protein in BER that processes potentially cytotoxic abasic sites (AP sites), is a promising new target in cancer. In the current study, we aimed to develop small molecule inhibitors of APE1 for cancer therapy. An industry-standard high throughput virtual screening strategy was adopted. The Sybyl8.0 (Tripos, St Louis, MO, USA) molecular modelling software suite was used to build inhibitor templates. Similarity searching strategies were then applied using ROCS 2.3 (Open Eye Scientific, Santa Fe, NM, USA) to extract pharmacophorically related subsets of compounds from a chemically diverse database of 2.6 million compounds. The compounds in these subsets were subjected to docking against the active site of the APE1 model, using the genetic algorithm-based programme GOLD2.7 (CCDC, Cambridge, UK). Predicted ligand poses were ranked on the basis of several scoring functions. The top virtual hits with promising pharmaceutical properties underwent detailed in vitro analyses using fluorescence-based APE1 cleavage assays and counter screened using endonuclease IV cleavage assays, fluorescence quenching assays and radiolabelled oligonucleotide assays. Biochemical APE1 inhibitors were then subjected to detailed cytotoxicity analyses. Several specific APE1 inhibitors were isolated by this approach. The IC50 for APE1 inhibition ranged between 30 nM and 50 μM. We demonstrated that APE1 inhibitors lead to accumulation of AP sites in genomic DNA and potentiated the cytotoxicity of alkylating agents in melanoma and glioma cell lines. Our study provides evidence that APE1 is an emerging drug target and could have therapeutic application in patients with melanoma and glioma.

AP endonuclease 1: Biological updates and advances in activity analysis

Molecular snapshots of APE1 proofreading mismatches and removing DNA damage

Functions of the major abasic endonuclease (APE1) in cell viability and genotoxin resistance

DNA Nanotechnology-Empowered Fluorescence Imaging of APE1 Activity

Function and expression regulation of apurinic/apyrimidinic endonuclease 1

Inner Amino Acid Contacts Are Key Factors of Multistage Structural Rearrangements of DNA and Affect Substrate Specificity of Apurinic/Apyrimidinic Endonuclease APE1

A DNA/RNA Hybrid Fluorescent Probe for High-Throughput Quantification of the Activity of Human Apurinic/apyrimidinic Endonuclease 1 in Subcellular Extracts

The APE1/REF-1 and the hallmarks of cancer

Expression and Subcellular Localization of Human AP Endonuclease 1 (hap1/ref‐1) Protein: a Basis for Its Role in Human Disease

Base Excision Repair in Mitotic Cells and the Role of Apurinic/Apyrimidinic Endonuclease 1 (APE1) in Post-Mitotic Transcriptional Reactivation of Genes

The Apurinic/apyrimidinic Endonuclease (Ape/ref-1) DNA Repair Enzyme is Elevated in Premalignant and Malignant Cervical Cancer.

Live-cell imaging of human apurinic/apyrimidinic endonuclease 1 in the nucleus and nucleolus using a chaperone@DNA probe

DNA/RNA Hybrid-Based Fluorescent Probe Enabled One-Step Detection of the Subcellular Activities of Human Apurinic/Apyrimidinic Endonuclease 1

Nanoscale Interaction of Endonuclease APE1 with DNA

Activity Assay and Intracellular Imaging of APE1 Assisted with Tetrahedral DNA Nanostructure Modified-Dnazyme and Molecular Beacon

Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of Ape1.

Development and Evaluation of Human AP Endonuclease Inhibitors in Melanoma and Glioma Cell Lines.

Design and activity of AP endonuclease-1 inhibitors

Nanoscale interaction of endonuclease APE-1 with DNA characterized by atomic force microscopy

Enhancing APE1 Detection Through Apurinic/apyrimidinic Site Inhibition of DNA Polymerase: an Innovative, Highly Sensitive Approach

Unimolecular Chemically Modified DNA Fluorescent Probe for One-Step Quantitative Measurement of the Activity of Human Apurinic/Apyrimidinic Endonuclease 1 in Biological Samples.